Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials
Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S
Published in BJOG: An International Journal of Obstetrics and Gynaecology
Methodology
Systematic review and meta-analysis of randomised trials comparing inositol with placebo or metformin for ovulation, clinical pregnancy and metabolic outcomes in women with PCOS.
Key Findings
Inositol improved ovulation rate and cycle frequency versus placebo and produced metabolic improvements comparable to metformin, but evidence for clinical pregnancy and live birth was insufficient.
Conclusions
Inositol improves ovulation and metabolic profile in PCOS; fertility outcome data remain inadequate.
Limitations
Included trials were small and of moderate quality with short follow-up and few hard reproductive outcomes.
Supplements Studied
Inositol improved ovulation rate and cycle frequency versus placebo and produced metabolic improvements comparable to metformin.
Outcomes Measured
Inositol improved ovulation rate and menstrual cycle frequency versus placebo.
Inositol improved ovulation rate and menstrual cycle frequency versus placebo.
Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials
Inositol improved ovulation rate and menstrual cycle frequency versus placebo.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Academic institutional funding
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.